Insights: Alerts 5 Key Takeaways: Patent Litigation Trends
Kilpatrick Townsend attorneys Andy Rinehart and Dr. Jennifer Giordano-Coltart recently presented their assessment of trends in patent litigation and prosecution at the firm’s annual patent CLE in Research Triangle Park. Twenty firm attorneys presented on top patent law issues to over 100 guests representing legal counsel from dozens of companies. Top takeaways from the analysis of patent litigation trends:
- Patent litigation actions in U.S. District Courts continue to decline steadily from their peak in 2013. Since that time, there has been a 21.6% decrease in the number of actions filed per year.
- Actions filed in the Eastern District of Texas, the most popular venue for patent infringement actions, decreased in 2016 by more than 33% relative to 2015, although the venue still had 1,685 new actions in 2016. By comparison, the District of Delaware was the second-most popular venue with 456 actions filed in 2016.
- Section 337 Investigations instituted in the International Trade Commission increased significantly in 2016 to a total of 57—an increase of 57% from 2015.
- The number of petitions for inter partes review (IPR) decreased from 2015, but the number of total filings still remained high with 1,565 petitions filed with the Patent Trial and Appeal Board (PTAB) in 2016.
- Patent Owners still face an uphill battle in proceedings before the PTAB—only 17% of all proceedings that receive a Final Written Decision in IPR result in all challenged claims found patentable. 23% of all IPR petitions result in all claims instituted being found
unpatentable, and 63% of petitions that reach an institution decision are granted.
Mr. Rinehart focuses his practice on patent litigation matters. Before attending law school, he was a Captain in the United States Army and the North Carolina National Guard, where he served in several command and staff assignments. Dr. Jennifer Giordano-Coltart advises businesses on patent matters in the areas of biotechnology, life sciences, pharmaceuticals, and medical devices.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.